-transparent.png){kind=logo}
To clarify the intrahepatical transport mechanism of cefpiramide, we investigated effects of various agents mainly excreted into the bile by several different mechanisms on the biliary excretion of cefpiramide in rats. Sulfobromophthalein, indocyanine green, bilirubin and probenecid, known to be bound to glutathione S-transferases (GST) (EC 2.5.1.18) in liver cytosol, reduced the biliary excretion of cefpiramide, while neither secretory IgA, which is transported via vesicles in the liver, nor colchicine, which inhibits movements of vesicles, had any effect on the excretion of cefpiramide. Propranolol and metoprolol, metabolized by mixed function oxidases, had no effect on the biliary excretion of cefpiramide. In the chromatography of liver cytosol, the amount of sulfobromophthalein or benzylpenicillin bound to the GST fraction decreased in the presence of cefpiramide or probenecid. The study showed that cefpiramide was transported in the liver without relation to mixed function oxidases or vesichle-mediated transporting system, but in relation to GST which binds cefpiramide, sulfobromophthalein, benzylpenicillin and probenecid, indicating an important role of GST in the cefpiramide excretion into the bile.
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
January 1980,
The Biochemical journal,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
September 1986,
Journal of lipid research,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
September 1982,
Biochemical and biophysical research communications,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
July 2001,
Chemical research in toxicology,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
December 1981,
The Japanese journal of experimental medicine,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
August 1988,
Biochemical pharmacology,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
May 1976,
Biochemical and biophysical research communications,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
December 1985,
Chemical & pharmaceutical bulletin,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
September 1983,
Research communications in chemical pathology and pharmacology,
A Guji, and
H Nishiya, and
M Aoki, and
I Ohyatsu, and
M Yamaguchi, and
Y Tokumura, and
H Sugiyama, and
T Miyashita, and
Y Ono, and
O Kunii
August 1985,
The Journal of biological chemistry,
